CMAP and Myosin-Loss Pathology in Patients With Critical Illness Myopathy

2024-09-19

Neurology Minute

0:00

1:50

Drs. Gordon Smith, Shahar Shelly, and Teerin Liewluck discuss the correlation between CMAP duration and myosin loss and their effect on mortality by comparing between patients with CIM with and without myosin loss.

Show references: https://www.neurology.org/doi/10.1212/WNL.0000000000209496

Fler avsnitt från "Neurology Minute"

The Placebo Effect
maŋit 20 diimmut
1:02
Dr. Gregg Day and Dr. Kathryn T. Hall discuss the complexities of the placebo effect, its variability among patients, and the genetic factors that influence responses to placebo treatments.
CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 2
maŋit 2 beaivvit
2:23
In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Ahmad Nehme discuss the underlying pathophysiology and how to diagnose primary angiitis of the CNS in clinical practice. Show reference: https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209548
Missa inte ett avsnitt av “Neurology Minute” och prenumerera på det i GetPodcast-appen.
CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 1
maŋit 3 beaivvit
2:11
In part one of this three-part series, Dr. Justin Abbatemarco and Dr. Ahmad Nehme discuss how cerebral amyloid angiopathy and CAA-RI present in clinical practice and how to make a diagnosis. Show reference: https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209548
Lab Minute - Vitamin D
2024-11-12
4:28
Dr. Stacey Clardy discusses vitamin D in this lab minute.
Could Reducing Environmental Toxins Help Mitigate the Risk for Parkinson’s Disease? Where the Evidence Is Leading
2024-11-11
4:28
Dr. Halley Alexander discusses the Neurology Today article, "Could Reducing Environmental Toxins Help Mitigate the Risk for Parkinson’s Disease? Where the Evidence Is Leading" by Gina Shaw, available in the November 7th issue of Neurology Today or at neurologytoday.com. Show reference: https://journals.lww.com/neurotodayonline/pages/articleviewer.aspx?year=2024&issue=11070&article=00001&type=Fulltext
Genetic Leukodystrophies Mimicking CNS Inflammation - Part 3
2024-11-08
1:58
In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Jennifer L. Orthmann Murphy highlight important indicators for when to suspect hereditary spastic paraplegia, as well as guidelines for testing and interpreting results. Show references: https://www.neurology.org/doi/10.1212/NXG.0000000000200192 https://cshperspectives.cshlp.org/content/early/2024/08/10/cshperspect.a041457
Genetic Leukodystrophies Mimicking CNS Inflammation - Part 2
2024-11-07
2:17
In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Jennifer L. Orthmann Murphy discuss practical approaches to genetic adrenoleukodystrophy. Show references: https://www.neurology.org/doi/10.1212/NXG.0000000000200192
Genetic Leukodystrophies Mimicking CNS Inflammation - Part 1
2024-11-06
2:06
In the first part of this three-part series, Dr. Justin Abbatemarco and Dr. Jennifer L. Orthmann Murphy discuss red flag symptoms that suggest the need for genetic testing in patients with white matter disease. Show references: https://www.neurology.org/doi/10.1212/NXG.0000000000200192 https://cshperspectives.cshlp.org/content/early/2024/08/10/cshperspect.a041457
Early Treatment Cuts Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
2024-11-05
2:56
Dr. Rae Bacharach discusses the Neurology Today article, “Early Treatment Cuts Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease,” by Gina Shaw, available in the latest issue of Neurology Today or at neurologytoday.com. Show reference: https://journals.lww.com/neurotodayonline/pages/default.aspx https://jamanetwork.com/journals/jamaneurology/article-abstract/2822964
Interventions for the Acute Management of Migraine Episodes in Adults - Part 3
2024-11-04
4:47
In the final part of this three-part series, Drs. Tesha Monteith, Messoud Ashina, and Andrea Cipriani discuss what you need to know about analyzing network meta-analysis. Show reference: https://www.bmj.com/content/386/bmj-2024-080107

Fler avsnitt

Kom åt alla poddsändningar i gratisappen GetPodcast.

Prenumerera på dina favoritpoddar, lyssna på avsnitt offline och få spännande rekommendationer.

CMAP and Myosin-Loss Pathology in Patients With Critical Illness Myopathy

Neurology Minute

Fler avsnitt från "Neurology Minute"

The Placebo Effect

CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 2

CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 1

Lab Minute - Vitamin D

Could Reducing Environmental Toxins Help Mitigate the Risk for Parkinson’s Disease? Where the Evidence Is Leading

Genetic Leukodystrophies Mimicking CNS Inflammation - Part 3

Genetic Leukodystrophies Mimicking CNS Inflammation - Part 2

Genetic Leukodystrophies Mimicking CNS Inflammation - Part 1

Early Treatment Cuts Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

Interventions for the Acute Management of Migraine Episodes in Adults - Part 3